201 related articles for article (PubMed ID: 33006443)
1. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.
Winnard PT; Bharti SK; Sharma RK; Krishnamachary B; Mironchik Y; Penet MF; Goggins MG; Maitra A; Kamel I; Horton KM; Jacobs MA; Bhujwalla ZM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1487-1500. PubMed ID: 33006443
[TBL] [Abstract][Full Text] [Related]
2. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
[TBL] [Abstract][Full Text] [Related]
3. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
4. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
5. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
6. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
7. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
[TBL] [Abstract][Full Text] [Related]
8. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
9. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
[TBL] [Abstract][Full Text] [Related]
11. Activated mast cells in skeletal muscle can be a potential mediator for cancer-associated cachexia.
Widner DB; Liu C; Zhao Q; Sharp S; Eber MR; Park SH; Files DC; Shiozawa Y
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1079-1097. PubMed ID: 34008339
[TBL] [Abstract][Full Text] [Related]
12. Altered Plasma Fatty Acid Abundance Is Associated with Cachexia in Treatment-Naïve Pancreatic Cancer.
Gumpper-Fedus K; Hart PA; Belury MA; Crowe O; Cole RM; Pita Grisanti V; Badi N; Liva S; Hinton A; Coss C; Ramsey ML; Noonan A; Conwell DL; Cruz-Monserrate Z
Cells; 2022 Mar; 11(5):. PubMed ID: 35269531
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice.
Jones-Bolin S; Ruggeri B
Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.3. PubMed ID: 21948162
[TBL] [Abstract][Full Text] [Related]
14. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
15. Review of the endocrine organ-like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma.
Yu YC; Ahmed A; Lai HC; Cheng WC; Yang JC; Chang WC; Chen LM; Shan YS; Ma WL
Front Oncol; 2022; 12():1057930. PubMed ID: 36465353
[TBL] [Abstract][Full Text] [Related]
16. Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia.
Uddin MH; Mohammad RM; Philip PA; Azmi AS; Muqbil I
Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1624-C1632. PubMed ID: 36280389
[TBL] [Abstract][Full Text] [Related]
17. Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.
Penet MF; Shah T; Bharti S; Krishnamachary B; Artemov D; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
Clin Cancer Res; 2015 Jan; 21(2):386-95. PubMed ID: 25370468
[TBL] [Abstract][Full Text] [Related]
18. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
[TBL] [Abstract][Full Text] [Related]
19. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
Winnard PT; Bharti SK; Penet MF; Marik R; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
Cancer Res; 2016 Mar; 76(6):1441-50. PubMed ID: 26719527
[TBL] [Abstract][Full Text] [Related]
20. Metabolic signatures imaged in cancer-induced cachexia.
Penet MF; Gadiya MM; Krishnamachary B; Nimmagadda S; Pomper MG; Artemov D; Bhujwalla ZM
Cancer Res; 2011 Nov; 71(22):6948-56. PubMed ID: 21948967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]